Home
BCLS Fund III Investments reported a 3.1% stake in Dianthus Therapeutics DNTH · 1,315,892 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 3.1%
- Last report
- 7.5% · filed 25/08/14
- Shares held
- 1,315,892 sh
- Class
- Common Stock, $0.001 par value per share
- Event date
- 25/09/30
- Filed
- 25/11/14
3.1% stake · below 5%
- Stake
- 3.1%
- Last report
- 7.5%
- Since last report
- −4.4pp
Dianthus Therapeutics trades, last 26 weeks
What else happened in Dianthus Therapeutics around then
Filed or reported within 30 days of the trade day · 25/08/31~25/10/30BCLS Fund III Investments's other 5% stake reports
- BCLS Fund III Investments
5% stakeADARx Pharmaceuticals
5% stakeADARx Pharmaceuticals
ADRX
6.3% stake
6,728,970 sh
6.3% stake
Filed 10/01
- BCLS Fund III Investments
5% stakeHeartflow
5% stakeHeartflow
HTFL
9.8% stake
8,448,158 sh
9.8% stake
Filed 08/14
- BCLS Fund III Investments
5% stakeHeartflow
5% stakeHeartflow
HTFL
12.18% stake
10,448,158 sh
12.18% stake
Filed 05/15
- BCLS Fund III Investments
5% stakeHeartflow
5% stakeHeartflow
HTFL
14.9% stake
12,448,158 sh
14.9% stake
Filed 25/11/14
- BCLS Fund III Investments
5% stakeDianthus Therapeutics
5% stakeDianthus Therapeutics
DNTH
7.5% stake
2,482,250 sh
7.5% stake
Filed 25/08/14
